Journal of Clinical Lipidology
Volume 4, Issue 2 , Pages 113-119 , March 2010

Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women

  • Rasa Kazlauskaite, MD

      Affiliations

    • Department of Preventive Medicine, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding author:
    • ,
  • Lynda H. Powell, PhD

      Affiliations

    • Department of Preventive Medicine, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA
    • ,
  • Chaitanya Mandapakala, MD

      Affiliations

    • Department of Preventive Medicine, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA
    • ,
  • John F. Cursio, MS

      Affiliations

    • Department of Preventive Medicine, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA
    • ,
  • Elizabeth F. Avery, MSPH

      Affiliations

    • Department of Preventive Medicine, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA
    • ,
  • James Calvin, MD

      Affiliations

    • Section of Cardiology, Rush University Medical Center, 1700 W. Van Buren St, Ste 470, Chicago, IL 60612, USA

Received 22 December 2009 ,Accepted 29 January 2010.

References 

  1. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511
  2. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol. 1980;46:649–654
  3. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–1349
  4. Reis JP, von Muhlen D, Miller ER, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the united states adolescent population. Pediatrics. 2009;124:e371–e379
  5. Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2007;63:458–464
  6. El Harchaoui K, Arsenault BJ, Franssen R, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150:84–93
  7. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447–452
  8. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–693
  9. Young KA, Engelman CD, Langefeld CD, et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009;94:3306–3313
  10. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes. 2010;59:242–248
  11. Sam S, Haffner S, Davidson MH, et al. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008;57:2022–2027
  12. Pascot A, Lemieux S, Lemieux I, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care. 1999;22:1471–1478
  13. Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: The Study of Women's Health Across the Nation (SWAN) FatPatterning Study. Obesity. [In Press].
  14. National Health and Nutrition Examination Survey physician's examination procedures manual. 1999 & 2000. Available at: http://www.cdc.gov/nchs/data/nhanes/pe.pdf. Accessed February 4, 2010.
  15. Otvos J. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clin Cardiol. 1999;22(S2):II-21–II-27
  16. Engelman CD, Fingerlin TE, Langefeld CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008;93:3381–3388
  17. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001;24:925–932
  18. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615–625
  19. Ockene IS, Chiriboga DE, Stanek EJ, et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med. 2004;164:863–870
  20. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20:713–719
  21. Rye K-A, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 2009;50(Suppl):S195–S200
  22. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30:1549–1555
  23. Reis JP, von Muhlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008;159:41–48
  24. Maki KC, Rubin MR, Wong LG, et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol. 2009;3:289–296
  25. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb. 1992;12:671–674
  26. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29:2244–2246
  27. Matsuura F, Wang N, Chen W, Jiang X-C, Tall AR. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest. 2006;116:1435–1442
  28. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres J-P. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53:577–584
  29. Grimes DS. Are statins analogues of vitamin D?. Lancet. 2006;368:83–86
  30. Pérez-Castrillón JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007;99:903–905

PII: S1933-2874(10)00045-0

doi: 10.1016/j.jacl.2010.01.006

Journal of Clinical Lipidology
Volume 4, Issue 2 , Pages 113-119 , March 2010

Article Tools

* Image Usage & Resolution